M Ventures
Biotechnology · Venture Capital
74investments
10exits
$559Mraised by its portfolio in 12 months
438open roles in its portfolio
Overview
M Ventures is the strategic corporate venture capital arm of Merck KGaA, the German science and technology group based in Darmstadt. It invests in innovative startups in biotechnology, healthcare, electronics and advanced materials, and helps create new companies around breakthrough science. The fund was established in 2009 and is headquartered in Amsterdam, with investment teams in Europe, the United States and Israel.
Investor profile
Venture capitalInvestments
74
46 of them startups
Hiring now
15
438 open roles
Rounds in 12 months
14
$559M raised
Exits
10
Focusshare of its companies
Health Care 38%Biotechnology 31%Artificial Intelligence 21%Hardware 13%Food & Beverages 6%Consumer Electronics 6%Science & Engineering 6%Telecommunications 4%
Where its companies are
United States 24%United Kingdom 8%Germany 7%France 4%Denmark 1%Switzerland 1%Netherlands 1%
Stage of its companies
Series A 50%Pre-seed & seed 25%Series B 25%
Its companies, the freshest money firstAll 74 investments
Light CastVenture round · 2 mo ago
NanoSyrinxVenture round · 2 mo ago
RemepySeries A $36M · 2 mo ago
Enara BioVenture round · 4 mo ago · 2 roles
STORM TherapeuticsVenture round · 7 mo ago
NRG TherapeuticsVenture round · 8 mo ago
LucideanSeed $18M · 10 mo ago
NeurableSeries A $35M · 10 mo ago
FoRx TherapeuticsSeries A $50M · 10 mo ago
DISCO Pharmaceuticals GmbHVenture round · 11 mo ago
PLEASE READ THIS AGVenture round $285M · 11 mo ago
ferroelectric-memoryVenture round · 13 mo ago
Hiring fastestroles opened in 30 days
Co-investorscompanies they hold together
Similar investorstheir companies share markets and countries
Sources: 4 rounds in the press that name it
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Amsterdam
Netherlands
HQ
200-500 est. staff






Sofinnova Partners
Omega Funds
NEA
Octopus Ventures
Taiho Ventures
High-Tech Gründerfonds
Novartis Venture Fund
NFX
DCVC
Insight Partners
ARCH Venture Partners
RA Capital Management
Sofinnova Investments
OrbiMed
Foresite Capital
EcoR1 Capital
Nextech Invest